Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Cash from Investing Activities (2016 - 2024)

Jaguar Health (JAGX) has disclosed Cash from Investing Activities for 8 consecutive years, with -$215000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Cash from Investing Activities changed N/A to -$215000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was -$215000.0, a N/A change, with the full-year FY2024 number at -$231000.0, changed N/A from a year prior.
  • Cash from Investing Activities was -$215000.0 for Q4 2024 at Jaguar Health, up from -$361000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $10.5 million in Q4 2021 to a low of -$10.5 million in Q3 2021.
  • A 4-year average of -$106500.0 and a median of -$135500.0 in 2022 define the central range for Cash from Investing Activities.
  • Biggest YoY gain for Cash from Investing Activities was 99.47% in 2022; the steepest drop was 103.45% in 2022.
  • Jaguar Health's Cash from Investing Activities stood at -$7000.0 in 2020, then soared by 149785.71% to $10.5 million in 2021, then tumbled by 103.45% to -$361000.0 in 2022, then soared by 40.44% to -$215000.0 in 2024.
  • Per Business Quant, the three most recent readings for JAGX's Cash from Investing Activities are -$215000.0 (Q4 2024), -$361000.0 (Q4 2022), and -$56000.0 (Q3 2022).